Foresite Capital recently announced that it was bringing on board Dr. Molly He to the company as a venture partner. This appointment is a big move for the company which has been diversifying its investments into other fields of healthcare and also venturing into new markets across the globe. Dr. He brings to the table more than 15 years of experience and is expected to be an invaluable asset to the company as a whole especially when it comes to the evaluation of new investment prospects within the healthcare industry.
Speaking during the announcement which was made at the company’s headquarters in San Francisco, Dr. Jim Tananbaum described her as one of the leading and most respected research scientists in the world when it comes to matters dealing with next generation sequencing. Jim Tananbaum is the founder and current CEO of Foresite Capital, an equity firm that supports investment in healthcare companies working both within the private sector and in the public sector. Before coming to Foresite Capital, Dr. He worked at Illumina where she held the position of senior director. Most of her labor and research involved genomic and pharmaceutical research and development, a field that Foresite Capital is keen on pursuing and making an investment.
Jim Tananbaum is a trained and certified medical practitioner although most people know him more for his work as a venture capitalist than as a physician. His academic qualifications are not to be questioned as he is a holder of a BSEE and a BS from Yale University as well as an MS from MIT an MD from Harvard Medical School and finally an MBA earned from the Harvard Business School.
As a venture capitalist, Jim Tananbaum has been the man behind the funding for many healthcare investments in the US and some of his most notable investments include Amerigroup, Jazz Pharmaceuticals, Healtheon and Amira Pharmaceuticals. He currently serves as Foresite Capital’s Chef Executive Officer, a position that he had held since 2010 when he founded the company. So far he has more than 25 years of experience in both the medical and financial world, and it is these qualities that have propelled the company to where it is today. More details can be found on Bloomberg.